HPVC2016-108 Biopharmaceutical - Infliximab
- Contract Start Date
- 01 Feb 2016
- Contract End Date
- 30 Apr 2022
- Option Periods
For the provision of Biopharmaceutical Infliximab
The Principal Period commenced on 1st of February 2016 and ran until 30th of April 2018.
The first Contract Option period of two years was executed – effective from 1 May 2018 until 30 April 2020.
The second Contract Option of two years has been executed – effective from 1 May 2020 until 30 April 2022.
Option Periods Remaining
Sales Report Template
(You must be a registered supplier on the HPV website and have logged in to access the link above for the new reporting template.)